BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27856439)

  • 1. Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth.
    Toh CH; Castillo M
    AJNR Am J Neuroradiol; 2017 Feb; 38(2):288-293. PubMed ID: 27856439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gray-matter-specific MR imaging improves the detection of epileptogenic zones in focal cortical dysplasia: A new sequence called fluid and white matter suppression (FLAWS).
    Chen X; Qian T; Kober T; Zhang G; Ren Z; Yu T; Piao Y; Chen N; Li K
    Neuroimage Clin; 2018; 20():388-397. PubMed ID: 30128277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Predictions for Patients with Glioblastoma after Standard Treatment: Application of Contrast Leakage Information from DSC-MRI within Nonenhancing FLAIR High-Signal-Intensity Lesions.
    Kim SH; Cho KH; Choi SH; Kim TM; Park CK; Park SH; Won JK; Kim IH; Lee ST
    AJNR Am J Neuroradiol; 2019 Dec; 40(12):2052-2058. PubMed ID: 31727756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic Features on MR Imaging Classify Multifocal Glioblastomas in Different Prognostic Groups.
    Pérez-Beteta J; Molina-García D; Villena M; Rodríguez MJ; Velásquez C; Martino J; Meléndez-Asensio B; Rodríguez de Lope Á; Morcillo R; Sepúlveda JM; Hernández-Laín A; Ramos A; Barcia JA; Lara PC; Albillo D; Revert A; Arana E; Pérez-García VM
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):634-640. PubMed ID: 30923085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Peritumoral Brain Parenchyma Using Contrast-Enhanced 3D Fast Imaging Employing Steady-State Acquisition at 3T for Differentiating Metastatic Brain Tumors and Glioblastomas.
    Yamamoto J; Kakeda S; Shimajiri S; Nakano Y; Saito T; Ide S; Moriya J; Korogi Y; Nishizawa S
    World Neurosurg; 2018 Dec; 120():e719-e729. PubMed ID: 30165229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional Diagnostic Value of Unenhanced Computed Tomography plus Diffusion-Weighted Imaging Combined with Routine Magnetic Resonance Imaging Findings of Early-Stage Gliblastoma.
    Wang H; Liu Z; Zhang Y; Hou F; Fu W; Lin J; Liu Y; Liu X
    Biomed Res Int; 2020; 2020():1672736. PubMed ID: 32149081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.
    Kim R; Choi SH; Yun TJ; Lee ST; Park CK; Kim TM; Kim JH; Park SW; Sohn CH; Park SH; Kim IH
    Eur Radiol; 2017 Mar; 27(3):1176-1185. PubMed ID: 27357131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
    Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
    J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic Contrast-Enhanced MR Imaging of Nonenhancing T2 High-Signal-Intensity Lesions in Baseline and Posttreatment Glioblastoma: Temporal Change and Prognostic Value.
    Hwang I; Choi SH; Park CK; Kim TM; Park SH; Won JK; Kim IH; Lee ST; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
    AJNR Am J Neuroradiol; 2020 Jan; 41(1):49-56. PubMed ID: 31806595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastomas with and without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity present morphological and microstructural differences on conventional MR images.
    Han Q; Lu Y; Wang D; Li X; Ruan Z; Mei N; Ji X; Geng D; Yin B
    Eur Radiol; 2023 Dec; 33(12):9139-9151. PubMed ID: 37495706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced MR Imaging versus Contrast-enhanced US: A Comparison in Glioblastoma Surgery by Using Intraoperative Fusion Imaging.
    Prada F; Vitale V; Del Bene M; Boffano C; Sconfienza LM; Pinzi V; Mauri G; Solbiati L; Sakas G; Kolev V; D'Incerti L; DiMeco F
    Radiology; 2017 Oct; 285(1):242-249. PubMed ID: 28562204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and prognostic significance of non-enhancing cortical signal abnormality in glioblastoma.
    Lasocki A; Gaillard F; Tacey M; Drummond K; Stuckey S
    J Med Imaging Radiat Oncol; 2016 Feb; 60(1):66-73. PubMed ID: 26597591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR Imaging Characteristics Associate with Tumor-Associated Macrophages in Glioblastoma and Provide an Improved Signature for Survival Prognostication.
    Zhou J; Reddy MV; Wilson BKJ; Blair DA; Taha A; Frampton CM; Eiholzer RA; Gan PYC; Ziad F; Thotathil Z; Kirs S; Hung NA; Royds JA; Slatter TL
    AJNR Am J Neuroradiol; 2018 Feb; 39(2):252-259. PubMed ID: 29191871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features.
    Kickingereder P; Bonekamp D; Nowosielski M; Kratz A; Sill M; Burth S; Wick A; Eidel O; Schlemmer HP; Radbruch A; Debus J; Herold-Mende C; Unterberg A; Jones D; Pfister S; Wick W; von Deimling A; Bendszus M; Capper D
    Radiology; 2016 Dec; 281(3):907-918. PubMed ID: 27636026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI.
    Viel T; Talasila KM; Monfared P; Wang J; Jikeli JF; Waerzeggers Y; Neumaier B; Backes H; Brekka N; Thorsen F; Stieber D; Niclou SP; Winkeler A; Tavitian B; Hoehn M; Bjerkvig R; Miletic H; Jacobs AH
    J Nucl Med; 2012 Jul; 53(7):1135-45. PubMed ID: 22689925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of Histogram-Profile Analysis in Ring-Enhancing Intracranial Lesions.
    Kolakshyapati M; Hashizume A; Ochi K; Ueno H; Kaichi Y; Takayasu T; Takano M; Karlowee V; Akiyama Y; Awai K; Maruyama H; Sugiyama K; Kurisu K; Yamasaki F
    World Neurosurg; 2019 Nov; 131():e226-e236. PubMed ID: 31349079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal and multicentric glioblastoma: Improved characterisation with FLAIR imaging and prognostic implications.
    Lasocki A; Gaillard F; Tacey M; Drummond K; Stuckey S
    J Clin Neurosci; 2016 Sep; 31():92-8. PubMed ID: 27343042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous radiographic resolution and subsequent redemonstration of an untreated glioblastoma.
    Takagi I; Shakur SF; Lukas RV; Eller TW
    J Neurosurg; 2011 Jul; 115(1):24-9. PubMed ID: 21476808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas.
    Liu TT; Achrol AS; Mitchell LA; Du WA; Loya JJ; Rodriguez SA; Feroze A; Westbroek EM; Yeom KW; Stuart JM; Chang SD; Harsh GR; Rubin DL
    AJNR Am J Neuroradiol; 2016 Apr; 37(4):621-8. PubMed ID: 26744442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juxtacortical Lesions in Multiple Sclerosis: Assessment of Gray Matter Involvement Using Phase Difference-enhanced Imaging (PADRE).
    Futatsuya K; Kakeda S; Yoneda T; Ueda I; Watanabe K; Moriya J; Murakami Y; Ide S; Ogasawara A; Ohnari N; Okada K; Adachi H; Korogi Y
    Magn Reson Med Sci; 2016 Oct; 15(4):349-354. PubMed ID: 26841855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.